Answers are grounded in this paper and cite their sources.
The clinical status and survival three years after first treatment were evaluated in 86 patients with reticulum-cell sarcoma. The results are given in detail, according to the site of the original tumor. Prognosis is less favorable than in Hodgkin's disease. Two factors, however, emerge: occasional unexpectedly long survival in the presence of extensive disease and unpredictability of the course of the disease. The authors recommend an energetic approach to the treatment of metastases with the aim of permanent control.
No takes yet. Share an insight, caveat, or question.
Newall et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: